T1	intervention 0 32	Dose-dense adjuvant chemotherapy
T3	age 392 407	> or = 60 years
T4	control 500 521	conventional-schedule
T5	intervention-participants 567 570	104
T6	control-participants 851 854	107
T7	outcome 1022 1028	Delays
T8	iv-bin-percent 1098 1101	17%
T9	iv-bin-percent 1109 1111	6%
T10	cv-bin-percent 1117 1120	11%
T11	cv-bin-percent 1128 1130	6%
T12	outcome 1141 1162	Grades 3-4 leukopenia
T13	iv-bin-percent 1164 1167	26%
T14	cv-bin-percent 1175 1178	12%
T15	outcome 1184 1195	neutropenia
T16	iv-bin-percent 1197 1200	33%
T17	cv-bin-percent 1208 1211	25%
T2	eligibility 37 92	node-positive breast cancer in women 60 years and older
T18	eligibility 255 302	older patients with node-positive breast cancer
